Simultaneous humoral and cellular immune response against cancer-testis antigen NY-ESO-1: Definition of human histocompatibility leukocyte antigen (HLA)-A2-binding peptide epitopes

Journal of Experimental Medicine

Volumn 187, Issue 2, 1998, Pages 265-270

  Jäger, Elke ^a   Chen, Yao Tseng ^b,c   Drijfhout, Jan W ^d   Karbach, Julia ^a   Ringhoffer, Mark ^a   Jäger, Dirk ^a   Arand, Michael ^e   Wada, Hisashi ^c   Noguchi, Yuji ^c   Stockert, Elisabeth ^c   Old, Lloyd J ^c   Knuth, Alexander ^a  

^a KRANKENHAUS NORDWEST   (Germany)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Australia)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; HLA A2 ANTIGEN; TUMOR ANTIGEN;

AGED; ANTIGEN RECOGNITION; ARTICLE; CASE REPORT; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; IMMUNOREACTIVITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA; PRIORITY JOURNAL;

AGED; AGED, 80 AND OVER; ANTIBODIES, NEOPLASM; ANTIGENS, NEOPLASM; BINDING SITES, ANTIBODY; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HLA-A2 ANTIGEN; HUMANS; IMMUNODOMINANT EPITOPES; LYMPHOCYTE CULTURE TEST, MIXED; MALE; MELANOMA; MEMBRANE PROTEINS; PEPTIDES; PROTEINS; T-LYMPHOCYTES, CYTOTOXIC; TESTIS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 2642683198     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.2.265     Document Type: Article

References (27)

1. Boon, T., and P. van der Bruggen. 1996. Human tumor antigens recognized by T lymphocytes. J. Exp. Med. 183:725-729.
2. Disis, M.L., and M.A. Cheever. 1996. Oncogenic proteins as tumor antigens. Curr. Opin. Immunol. 8:637-642.
3. Knuth, A., B. Danowski, H.F. Oettgen, and L.J. Old. 1984. T-cell-mediated cytotoxicity against autologous malignant melanoma: analysis with interleukin-2-dependent T-cell cultures. Proc. Natl. Acad. Sci. USA. 81:3511-3515.
4. Old, L.J. 1981. Cancer immunology: the search for specificity. Cancer Res. 41:361-375.
5. Sahin, U., Ö. Türeci, H. Schmitt, U. Cochlovius, T. Johannes, R. Schmits, F. Stenner, G. Luo, I. Schobert, and M. Pfreundschuh. 1995. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. USA. 92:11810-11813.
6. Rosenberg, S.A. 1996. Development of cancer immunotherapies based on identification of the genes encoding cancer regression antigens. J. Natl. Cancer Inst. 88:1635-1644.
7. Brichard, V., A. Van Pel, T. Wölfel, C. Wölfel, E. DePlaen, B. Lethe, P. Coulie, and T. Boon. 1993. The tyrosinase gene codes for an antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 178: 489-495.
8. Bakker, A.B., M.W.J. Schreurs, A.J. deBoer, Y. Kawakami, S.A. Rosenberg, G.J. Adema, and C.G. Figdor. 1994. Melanocyte lineage-specific antigen gp100 is recognized by melanoma-derived tumor-infiltrating lymphocytes. J. Exp. Med. 179:1005-1009.
9. Coulie, P.G., V. Brichard, A. Van Pel, T. Wölfel, J. Schneider, C. Traversari, S. Mattei, E. DePlaen, C. Lurquin, J.-P. Szikora, et al. 1994. A new gene coding for a differentiation antiqen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas. J. Exp. Med. 180:35-42.
10. Coulie, P.G., F. Lehmann, B. Lethe, J. Herman, C. Lurquin, M. Andrawiss, and T. Boon. 1995. A mutated intron sequence codes for an antigenic peptide recognized by cytolytic T lymphocytes on a human melanoma. Proc. Natl. Acad. Sci. USA. 92:7976-7980.
11. Wölfel, T., M. Hauer, J. Schneider, M. Serrano, C. Wölfel, E. Klehmann-Hieb, E. DePlaen, T. Hankeln, K.-H. Meyer zum Büschenfelde, and D. Beach. 1995. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science. 269:1281-1284.
12. Van der Bruggen, P., C. Traversari, P. Chomez, C. Lurquin, E. De Plaen, B. Van den Eynde, A. Knuth, and T. Boon. 1991. A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 254:1643-1647.
13. Jäger, E., M. Ringhoffer, H.-P. Dienes, M. Arand, J. Karbach, D. Jäger, C. Ilsemann, M. Hagedorn, F. Oesch, and A. Knuth. 1996. Granulocyte macrophage colony-stimulating factor enhances immune responses to melanoma associated peptides in vivo. Int. J. Cancer. 67:54-62.
14. Jäger, E., M. Ringhoffer, M. Altmannsberger, M. Arand, J. Karbach, D. Jäger, F. Oesch, and A. Knuth. 1997. Immunoselection in vivo: independent loss of MHC class I and melanocyte differentiation antigen expression in metastatic melanoma. Int. J. Cancer. 71:142-147.
15. Chen, Y.-T., M.J. Scanlan, U. Sahin, Ö. Türeci, A.O. Gure, S. Tsang, B. Williamson, E. Stockert, M. Pfreundschuh, and L.J. Old. 1997. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. USA. 94:1914-1918.
16. Türeci, O., U. Sahin, I. Schobert, M. Koslowski, H. Schmitt, H.J. Schild, F. Stenner, G. Seitz, H.G. Rammensee, and M. Pfreundschuh. 1996. The SSX-2 gene, which is involved in the t(X;18) translocation of synovial sarcomas, codes for the human tumor antigen HOM-MEL-40. Cancer Res. 56:4766-4772.
17. Herin, M., C. Lemoine, P. Weynants, F. Vessiere, A. Van-Pel, A. Knuth, R. Devos, and T. Boon. 1987. Production of stable cytolytic T cell clones directed against autologous human melanoma. Int. J. Cancer. 39:390-396.
18. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA. 76:4350-4354.
19. D'Amaro, J., J.G.A. Houbiers, J.W. Drijfhout, R.M.P. Brandt, R. Schipper, J.N. Bouwes Bavinck, C.J.M. Melief, and W.M. Kast. 1995. A computer program for predicting possible cytotoxic T lymphocyte epitopes based on HLA class I peptide-binding motifs. Hum. Immunol. 43:13-18.
20. Traversari, C., P. van der Bruggen, B. van den Eynde, P. Hainaut, C. Lemoine, N. Ohta, L.J. Old, and T. Boon. 1992. Transfection and expression of gene coding for a human melanoma antigen recognized by autologous cytolytic T lymphocytes. Immunogenetics. 35:145-148.
21. Knuth, A., T. Wölfel, E. Klehmann, T. Boon, and K.-H. Meyer zum Büschenfelde. 1989. Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection. Proc. Natl. Acad. Sci. USA. 86:2804-2808.
22. Knuth, A., T. Wölfel, and K.-H. Meyer zum Büschenfelde. 1992. T cell responses to human malignant tumours. Cancer Surv: 13:39-52.
23. Mukherji, B., and T.J. MacAlister. 1983. Clonal analysis of cytotoxic T cell response against human melanoma. J. Exp. Med. 158:240-244.
24. Muul, L.M., P.J. Spiess, E.P. Director, and S.A. Rosenberg. 1987. Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. J. Immunol. 138:989-995.
25. Marchand, M., P. Weymants, E. Rankin, F. Arienti, F. Belli, G. Parmiani, N. Cascinelli, A. Bourlond, R. Vanwjick, Y. Humblet, et al. 1995. Tumor regression responses in melanoma patients treated with a peptide encoded by gene MAGE-3. Int. J. Cancer. 63:883-885.
26. Jäger, E., M. Arand, M. Ringhoffer, J. Karbach, D. Jäger, C. Ilsemann, M. Hagedorn, F. Oesch, and A. Knuth. 1996. Cytolytic T cell reactivity against melanoma associated differentiation antigens in peripheral blood of melanoma patients and healthy individuals. Melanoma Res. 6:419-425.
27. Yee, C., M.J. Gilbert, S.R. Ridell, V.G. Brichard, A. Fefer, J.A. Thompson, T. Boon, and P.D. Greenberg. 1996. Isolation of tyrosinase-specific CD8+ and CD4+ T cell clones from the peripheral blood of melanoma patients following in vitro stimulation with recombinant vaccinia virus. J. Immunol. 157:4079-4086.